activities in acrylonitrile butadiene styrene production, located in Tarragona. Ineos paid EUR35 million in a first tranche. In March 2010 Ineos Healthcare terminated its drug development programme for commercial reasons.

Establishment of a biorefinery

Ineos Bio broke ground on the Vero Beach demonstration plant in February 2011. The facility used a gasification fermentation process to convert cellulosic waste materials, such as yard

1.Previous
3.Next